| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/20/2007 | WO2007104895A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | WO2007104771A1 Orodispersible domperidone tablets |
| 09/20/2007 | WO2007104748A2 Improved process for producing a solid dispersion of an active ingredient |
| 09/20/2007 | WO2007104747A2 Process for producing a solid dispersion of an active ingredient |
| 09/20/2007 | WO2007104575A2 Stable lozenge compositions providing rapid release of nicotine |
| 09/20/2007 | WO2007104574A2 Chewing gum compositions providing rapid release of nicotine |
| 09/20/2007 | WO2007104573A2 Improved snuff composition |
| 09/20/2007 | WO2007104298A2 Regeneratable filter for extracorporal treatment of liquids containing particles and use thereof |
| 09/20/2007 | WO2007104268A1 A method for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel, their use and devices for their production |
| 09/20/2007 | WO2007104173A2 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
| 09/20/2007 | WO2007104108A1 Non-codeine opioid analgesic process and formulations |
| 09/20/2007 | WO2007087759A3 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 09/20/2007 | WO2007087416A3 Methods of increasing oral bioavailability of tetracyclines |
| 09/20/2007 | WO2007086914A3 Nanoparticulate clopidogrel formulations |
| 09/20/2007 | WO2007079198A3 Metaxalone formulations and methods for the preparation thereof |
| 09/20/2007 | WO2007074454A3 Stable enzymatic preparations and methods of use thereof |
| 09/20/2007 | WO2007072535A8 Microparticulate systems for the oral administration of biologically active substances |
| 09/20/2007 | WO2007072495A3 Coated tablets having prolonged gastric retention |
| 09/20/2007 | WO2007072297A3 Device for controlled release of chemical molecules |
| 09/20/2007 | WO2007070851A3 Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
| 09/20/2007 | WO2007070705A3 Cationic lipid-mediated vectors |
| 09/20/2007 | WO2007065017A3 Oligonucleotide cationic liposomal delivery system |
| 09/20/2007 | WO2007063335A3 Amphotericin b salt |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007053392A3 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 09/20/2007 | WO2007050975A3 Hydrophilic vehicle-based dual controlled release matrix system as capsule fill |
| 09/20/2007 | WO2007050724A3 Lipophilic vehicle-based dual controlled release matrix system as capsule fill |
| 09/20/2007 | WO2007050580A3 Transdermal drug delivery system with acrylate or methacrylate functional pressure sensitive adhesive composition |
| 09/20/2007 | WO2007047539A3 Localized delivery to the lymphatic system |
| 09/20/2007 | WO2007036376A3 Skincare products |
| 09/20/2007 | WO2007033193A3 Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 09/20/2007 | WO2007024265A3 Oral care compositions |
| 09/20/2007 | WO2007019184A3 Oral suspension of prednisolone acetate |
| 09/20/2007 | WO2007014328A2 Compositions and methods for emulsifying a perfluorocarbon with an oxygen-carrying surfactant |
| 09/20/2007 | WO2007011922A3 Bioelectro-osmotic engine fluid delivery device |
| 09/20/2007 | WO2007010559A3 Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor |
| 09/20/2007 | WO2007009014A3 Personal topical disinfectant device |
| 09/20/2007 | WO2006126208A3 Compositions and methods using same for delivering agents into a target organ protected by a blood barrier |
| 09/20/2007 | WO2006123357A3 Oral controlled release composition containing levetiracetam |
| 09/20/2007 | WO2006105102A3 Synthesis of nanostructured materials using liquid crystalline templates |
| 09/20/2007 | WO2006082596A3 Neem oil contraceptive formulations |
| 09/20/2007 | WO2006065675A3 Method and compositions for preparing and delivering lipids, other nutrients and medicaments |
| 09/20/2007 | WO2005120152A3 Cationic lipids and methods of use |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | US20070219583 System And Method For Facilitating Hemostatis With An Absorbable Sponge |
| 09/20/2007 | US20070219538 Implantable Therapeutic Substance Delivery Device Having a Piston Pump with an Anti-Cavitation Valve |
| 09/20/2007 | US20070219286 Adhesive For Dermal Patch And Production Process Thereof |
| 09/20/2007 | US20070219271 Pharmaceutical Compositions Containing Pufa And At Least One Of An Immunosuppressive Agent Or An Antineoplastic Agent |
| 09/20/2007 | US20070219250 Pharmaceutical Compositions of Nateglinide |
| 09/20/2007 | US20070219231 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
| 09/20/2007 | US20070219175 Controlled Release Pharmaceutical Composition Comprising An Acid-Insoluble And A Bioadhesive Polymer |
| 09/20/2007 | US20070219171 Transdermal Pharmaceutical Spray Formulations Comprising a Vp/Va Copolymer and a Non-Aquous Vehicle |
| 09/20/2007 | US20070219169 Pharmaceutical compositions comprising trimegestone |
| 09/20/2007 | US20070219162 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye |
| 09/20/2007 | US20070219157 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
| 09/20/2007 | US20070219142 Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye |
| 09/20/2007 | US20070219131 Compositions capable of facilitating penetration across a biological barrier |
| 09/20/2007 | US20070218555 Anti-Microbial Activity Of Biologically Stabilized Silver Nano Particles |
| 09/20/2007 | US20070218142 Pharmaceutical Formulations For The Prolonged Release Of Interleukins And Their Therapeutic Applications |
| 09/20/2007 | US20070218141 Simvastatin compositions |
| 09/20/2007 | US20070218140 Slow-Release Preparations And Their Method Of Production |
| 09/20/2007 | US20070218139 High Pressure Compaction For Pharmaceutical Formulations |
| 09/20/2007 | US20070218138 Pharmaceutical Compositions |
| 09/20/2007 | US20070218137 Sustained release matrix systems for highly soluble drugs |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | US20070218135 Sustained release matrix pharmaceutical composition |
| 09/20/2007 | US20070218134 Compositions Comprising Organic Compounds |
| 09/20/2007 | US20070218133 Sustained release additives for fermentation products |
| 09/20/2007 | US20070218131 Effervescent formulations comprising desmopressin |
| 09/20/2007 | US20070218130 Bisphosphonate composition and process for the preparation thereof |
| 09/20/2007 | US20070218129 Solid Dispersible and/or Orodispersible Non-Filmy Containing at Least One Type of Active Substance Pharmaceutical Composition and Method for the Preparation Thereof |
| 09/20/2007 | US20070218128 Manufacturing of Quick Release Pharmaceutical Compositions of Water Insoluble Drugs and Pharmaceutical Compositions Obtained By the Process of the Invention |
| 09/20/2007 | US20070218127 Capsules Derived From Asymmetrical Production |
| 09/20/2007 | US20070218126 Compositions and Methods for Reducing Inflammation and Pain Associated with Acidosis |
| 09/20/2007 | US20070218125 Gi Track Delivery Systems |
| 09/20/2007 | US20070218124 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means |
| 09/20/2007 | US20070218123 Polymersomes and related encapsulating membranes |
| 09/20/2007 | US20070218122 siRNA silencing of influenza virus gene expression |
| 09/20/2007 | US20070218121 Compounds that inhibit caspase activity for treating glaucoma |
| 09/20/2007 | US20070218120 Ph Sensitive Block Copolymer and Polymeric Micelle Using the Same |
| 09/20/2007 | US20070218119 Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation |
| 09/20/2007 | US20070218118 Methods and compositions for treating post- myocardial infarction damage |
| 09/20/2007 | US20070218117 Supra molecular construct for delivery of interferon to a mammal |
| 09/20/2007 | US20070218116 Compositions and methods for the treatment of tumors and tumor metastases |
| 09/20/2007 | US20070218115 Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate |
| 09/20/2007 | US20070218114 Soluble Strip for Oral or Topical Administration |
| 09/20/2007 | US20070218104 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 09/20/2007 | US20070218103 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 09/20/2007 | US20070218093 Applicator and Method for Applying Lanolin to a Sore Nipple |
| 09/20/2007 | US20070218090 Dissolvable strip for delivery of an agent |
| 09/20/2007 | US20070218087 Method of controlled release of vanillin for nasal and/or pulmonary uptake |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218049 Nanoparticle based photodynamic therapy and methods of making and using same |
| 09/20/2007 | US20070218013 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections |
| 09/20/2007 | US20070218012 Spray drying a drug such as telaprevir; VX 770 is excluded; including a nonvolatile solvent during spray drying of a drug can improve the properties of resulting product |
| 09/20/2007 | US20070218011 Aerosol Formulation Comprising Formoterol in Suspension |
| 09/20/2007 | US20070217996 Activatable Particles, Preparations and Uses |
| 09/20/2007 | US20070217990 Silicone Vesicles |
| 09/20/2007 | US20070215511 Modified release formulations containing drug-ion exchange resin complexes |